New 5-HT1A receptor agonists possessing 1,4-Benzoxazepine scaffold exhibit highly potent anti-ischemic effects
- 1 February 2001
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 11 (4), 595-598
- https://doi.org/10.1016/s0960-894x(01)00008-7
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?Trends in Neurosciences, 1999
- Neuroprotective effect of 5-HT1A receptor agonist, Bay×3702, demonstrated in vitro and in vivoEuropean Journal of Pharmacology, 1998
- Role of hippocampal serotonergic neurons in ischemic neuronal deathBehavioural Brain Research, 1997
- MKC-242Drugs of the Future, 1997
- Regulation of glutamate release via NMDA and 5-HT1A receptors in guinea pig dentate gyrusBrain Research, 1996
- Current advances and trends in the treatment of depressionTrends in Pharmacological Sciences, 1994
- Neuropharmacology of anxiety: perspectives and prospectsTrends in Pharmacological Sciences, 1994
- Effects of serotonergic drugs in experimental brain ischemia: evidence for a protective role of serotonin in cerebral ischemiaBrain Research, 1993
- Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressantsLife Sciences, 1992
- Ischemia-induced extracellular release of serotonin plays a role in CA1 neuronal cell death in rats.Stroke, 1992